The E6 proteins of the high-risk Human papillomaviruses (HPV) types have a well-documented ability to target certain cellular proteins for ubiquitin-mediated degradation via the proteasome. Previous studies have shown that E6 proteins interact differently with different target proteins, and that the viral proteins, depending upon the target, may recruit diverse cellular ubiquitin-protein ligases. In this study, we have examined the abilities of E6 proteins from HPV-16 and HPV-18 to interact with and induce the degradation of two PDZ domain-containing targets, Dlg and hScrib. We have also mapped the binding site of E6 on hScrib and shown that the interaction of E6 with hScrib is distinct from its interactions with other PDZ domain-containing targets. This is reflected in the efficiency with which the two viral E6 proteins can inhibit hScrib's suppression of cell transformation.Dlg and hScrib have complementary activities in the control of epithelial cell polarity and the fact that both are targeted by high-risk HPV E6 proteins underlines their importance. Our finding that they are each targeted differently by HPV-16 and HPV-18 E6s suggests that the two viruses are subjected to somewhat different constraints and provides a possible explanation for the apparent redundancy in targeting both parts of this important control mechanism.
Introduction
Human papillomaviruses (HPVs) are small doublestranded DNA viruses. More than 100 virus types have been identified, each of which infects the cutaneous or mucosal epithelium at strictly defined anatomical sites. HPVs infect epithelial stem cells in the basal layer of the epithelium; their replication cycle depends on the differentiation programme of the epithelium and virion capsid assembly occurs only in the terminally differentiated keratinized layers of the epithelium. Thus, the interaction between the viral and cellular proteins needs to be carefully balanced to provide a suitable environment for viral protein expression and DNA replication whilst maintaining the epithelial differentiation. In some cases, this balance is lost and infection by certain HPV types can lead to cellular immortalization and eventually to malignancy, the best known of which is the association of cervical cancer with infection by the 'high-risk' mucosal HPV types, most commonly HPV-16 and HPV-18 (zur Hausen, 1991) .
Many studies in Drosophila have shown a highly complex interaction of proteins that are involved in the development and control of epithelial cell polarity (Bilder et al., 2000 (Bilder et al., , 2003 Tanentzapf and Tepass 2003; Bilder 2004) . These appear to be highly conserved in higher eukaryotes: the mammalian homologues of Dlg, Scribble and Lgl among others, have been shown to be able to complement Drosophila mutants lacking these proteins (Thomas et al., 1997; Dow et al., 2003; Grifoni et al., 2004) . Mutational studies in Drosophila have led to the classification of Dlg and Scribble (Bilder et al., 2000) as tumour suppressors, and each of the two proteins has been shown to be able to complement a lack of the other in at least some activities (Bilder et al., 2000) . Dlg is a member of the MAGUK (membrane associated guanylate kinase (GUK)) family of proteins and has a GUK domain, an SH3 domain and three PDZ domains (Woods and Bryant, 1991; Woods et al., 1996) . It is thought to be involved in forming molecular scaffolds on the basolateral membrane and is associated with mitotic spindle separation in both neuroblast and epithelial cells (Albertson and Doe, 2003; Massimi et al., 2003) . Scribble is a member of the LAP (leucine-rich and PDZ domain) family of proteins, having four PDZ domains and a Leucine-rich domain, which controls its localization to the basolateral membrane (Bryant and Huwe, 2000; Legouis et al., 2003) . Dlg and Scribble together form a complex whose function is required for the maintenance of correct epithelial polarity (reviewed in Humbert et al., 2003) . The high-risk HPV E6 proteins target both Dlg and Scribble (Kiyono et al., 1997; Lee et al., 1997; Gardiol et al., 1999; Nakagawa and Huibregtse, 2000) for degradation, and both Dlg (Watson et al., 2002 (Watson et al., , 2003 Cavatorta et al., 2004) and Scribble (Nakagawa et al., 2004) have been shown to be altered in HPV-induced tumours. More recent work suggests that Dlg may have a signalling role, a subset translocating to the nucleus upon the cell's attaining confluence, and that this signalling subset is the true target of the E6 proteins, while disruption of the polarity-controlling complex is an unfortunate and rare side effect, potentially leading to malignant conversion (Massimi et al., 2004) .
We were intrigued by the apparent redundancy of the HPV E6 oncoproteins targeting two functionally interdependent cellular targets. Therefore, in this study we have attempted to analyse the interactions of HPV-16 and HPV-18 E6 with human Scribble (hScrib), both with respect to their abilities to induce its degradation and to their abilities to abolish hScrib activity in vivo. The results demonstrate that the interactions, rather than being redundant, actually represent a fundamental difference in the biochemical and biological activities of the HPV E6 proteins with respect to their PDZ domaincontaining substrates.
Results

HPV E6 proteins target hScrib through its PDZ domains
It had previously been shown that the human homologue of Drosophila Scribble protein (hScrib) is targeted by the common HPV-16 E6 and the relatively rare and uncharacterized HPV-39 E6 proteins for ubiquitinmediated degradation via the proteasome, apparently using the E6-AP ubiquitin-protein ligase (Nakagawa and Huibregtse, 2000) . However, there was little precise information available on the binding site of E6 on hScrib. In addition, no information was available on whether other common high-risk HPV E6 proteins, such as HPV-18 E6, could also target Scribble, nor on the comparative abilities of different E6 proteins to target Scribble. This latter point seemed particularly relevant in light of the apparent redundancy in targeting both Scribble and Dlg when both are required for the regulation of epithelial apico-basal polarity Tanentzapf and Tepass, 2003) . To investigate this point, we performed in vitro degradation assays. In vitro translated, radiolabelled wild-type HAhScrib or mutant HA-hScrib lacking the PDZ domains (hScribDPDZ) were incubated at 301C with in vitro translated HPV-16 and HPV-18 E6 proteins. The remaining hScrib proteins were immunoprecipitated using an anti-HA antibody and then analysed by SDS-PAGE and autoradiography: the results can be seen in Figure 1a . It is clear that the wild-type hScrib, while completely stable in the absence of E6, is degraded efficiently in the presence of HPV-16 E6 and somewhat less efficiently in the presence of HPV-18 E6. The hScribDPDZ mutant appears to be unaffected by the presence of either HPV E6 protein. This clearly shows that the PDZ domains of hScrib are required for its interaction with E6. An hScrib protein mutated in its leucine-rich repeats (LRR) domain shows wild-type susceptibility to E6-induced degradation in vitro (data not shown), providing further confirmation that the PDZ domains are involved in binding.
In order to rule out the possibility that the deletion of the PDZ domains provokes a general misfolding of hScrib, we looked for the subcellular localization of GFP-hScribDPDZ in epithelial cells. We previously showed that the GFP-hScrib is targeted to the basolateral membrane of polarized MDCK cells in an LRR domain-dependent manner (Navarro et al., 2005) . We performed immunostaining and confocal analysis of MDCKII cells expressing a GFP-hScribDPDZ construct. Like GFP-hScrib (data not shown and Navarro et al., 2005) , GFP-hScribDPDZ colocalised with b-catenin, a marker of adherens junctions, at the basolateral membrane (Figure 1b ). This result demonstrates that the PDZ-deleted hScrib construct has conserved the structure and function, and that the lack of degradation in the presence of E6 is not due to a general misfolding of the protein. In showing that the PDZ domains of hScrib are required for its E6-induced degradation, we were interested to note that the HPV-16 E6 appeared to be more effective at inducing the degradation of hScrib than was HPV-18 E6. This was in marked contrast to previous findings that have shown that HPV-18 is more effective in inducing the degradation of PDZ domain-containing targets such as Dlg (Gardiol et al., 1999) , MAGIs -1, -2 and -3 (Glaunsinger et al., 2000; Thomas et al., 2001 Thomas et al., , 2002 , and MUPP1 (M Thomas unpublished observations). To confirm the observation, the in vitro degradation of hScrib was repeated in direct comparison with the degradation of Dlg. The assay was performed as before and the results are shown in Figure 2 , confirming that HPV-16 E6 targets hScrib for degradation more efficiently than HPV-18 E6, whereas HPV-18 E6 targets Dlg more efficiently than HPV-16 E6. (Saras and Heldin, 1996) . There are a number of classes of PDZ-binding motifs, but the classic one is found at the extreme carboxy terminus of the protein with the consensus sequence XT/SXV. HPV-18 E6's greater specificity for its PDZcontaining targets has been attributed to its having a perfect consensus sequence (ETQV), while the HPV-16 E6 PDZ binding motif differs slightly (ETQL). It was of interest to know whether the presence of a Leucine residue conferred the greater affinity for hScrib. To investigate this, we made use of PDZ-binding mutants of HPV-16 and HPV-18 E6, which are shown schematically in Figure 3a . The endswap mutants, HPV-16 L151V and HPV-18 V158L, differ from wild-type proteins only in the last amino acid, which has been changed from L to V and vice versa. These mutants were used in in vitro degradation assays as before and the results are shown in Figure 3b . As before, hScrib and Dlg are stable in the absence of E6 and, also as before, the wild-type HPV-16 E6 induces the degradation of hScrib more strongly than wild-type HPV-18 E6 does, the reverse being the case with Dlg. In the case of the endswap mutants the efficiency of degradation is completely reversed, demonstrating that the identity of the final amino acid has a profound effect upon the effectiveness of the interaction. Mutants previously shown to be non-PDZ binding had no effect on hScrib stability (data not shown).
A series of GST pulldown assays was also performed in which in vitro translated hScrib and Dlg were incubated with wild-type HPV-16 E6, HPV-18 E6, and with the HPV-18 E6V158L mutant expressed as GST fusion proteins. The proteins retained on the resin were washed extensively and then analysed by SDS-PAGE. The results from four assays are shown in Figure 3c and Table 1 , where it can clearly be seen that Dlg binds GST-HPV-18 E6 more strongly than it binds GST-HPV-16 E6, in agreement with previous studies (Pim et al., 2000) , whereas hScrib binds GST-HPV-16 E6 more strongly than it binds GST-HPV-18 E6. In addition, the GST-HPV-18 E6V158L exhibits an HPV-16-like pattern of binding to hScrib and to Dlg, thus confirming that the difference in induction of degradation is, at least partly, related to differences in ability to bind the target protein. GST alone was used as a negative control and no binding was seen.
HPV E6 proteins bind to hScrib PDZ domain 3 (PDZ3)
Having confirmed that the exact sequence of the PDZbinding motif of E6 has a profound effect upon its affinity for hScrib, albeit an opposite effect to that seen with any other PDZ domain-containing targets, we were obviously interested in the site on hScrib that was being bound. We had already shown that the hScribDPDZ mutant, which lacks the entire PDZ region, cannot be degraded by E6: however, that region contains four PDZ domains. A previous study had suggested that HPV-16 E6 can bind fusion proteins encompassing PDZ1 and PDZ2 or PDZ3 and PDZ4 of Scribble, implying that E6 binding to Scribble is very promiscuous (Nakagawa and Huibregtse, 2000) . More recent studies, however, suggest that the PDZ domains of many proteins are highly specific in their interactions with target proteins, which bind specifically to only one of the PDZ domains present (Dobrosotskaya and James, 2000; Dobrosotskaya, 2001; Mathew et al., 2002; Petit et al., 2005) . Furthermore, we had also previously shown for other E6 targets that the interaction is highly specific for only one PDZ domain in each protein (Glaunsinger et al., 2000; Gardiol et al., 2002; Thomas et al., 2002) . We therefore wished to map the E6-binding domain of hScrib in more detail. To do this, we first made use of GST fused to each individual PDZ domain of hScrib. These were expressed in Escherichia coli, extracted, bound to Glutathione agarose and used in GST pulldown assays with in vitro translated radiolabelled wild-type and endswap HPV E6 proteins. The results are shown in Figure 4a , where it can be seen that GST-PDZ3 is the only one bound to a significant degree. Since this was somewhat contradictory to previous studies, it was then necessary to perform the reverse binding assay; to do this we performed binding assays using GST-16E6 with in vitro translated wild-type hScrib and mutants of hScrib as follows: 4PDZ, consisting of the four PDZ domains only and 4PDZM1, 4PDZM2, 4PDZM3 and 4PDZM4 in which each of the PDZ domains in turn is mutated (Petit et al., 2005) . The results are shown in Figure 4b where it is clear that 4PDZ binds strongly to GST-16E6, and that only mutation of PDZ3 completely abrogates the binding. These data strongly indicate that the hScrib PDZ3 is the target PDZ domain of HPV E6.
HPV-16 E6 abrogates hScrib's inhibition of the immortalization of primary rodent cells
hScrib has been shown to be a potential tumour suppressor and is important in the regulation of epithelial polarity and development in Drosophila; therefore, it was obvious to examine the effect of HPV E6 proteins upon the potential transformation suppression activities of hScrib. To do this, BRK cells were transfected with HPV-16 E7 and EJ-ras together with hScrib and either HPV-16 E6 or HPV-18 E6. The lowrisk HPV-11 E6, which lacks a PDZ-binding motif, was included for comparison. The transfected cells were maintained under selection for 2 weeks and were then fixed, stained and any colonies were counted. The Table 1 . GST alone was included in each assay as a negative control and the % input retained was less than 1% in each case histogram in Figure 5 shows the collated results from at least three assays, while Table 2 shows the numbers of colonies obtained in each assay. It is clear that, as expected, the presence of hScrib markedly reduces the transformation induced by EJ-ras and E7. It is also clear that this suppression of transformation is strongly abrogated by HPV-16 E6, but that HPV-18 E6 is little more effective than HPV-11 E6, which completely lacks a PDZ binding domain. Thus, the ability of HPV E6 proteins to counteract the transformation suppression caused by hScrib directly correlates with their ability to induce the degradation of hScrib in vitro.
HPV-16 and HPV-18 E6 proteins induce the proteasomemediated degradation of hScrib in vivo
Having shown that the high-risk HPV E6 proteins can overcome hScrib suppression of cell transformation in a manner that correlates with their ability to target hScrib for degradation in vitro, it was then necessary to ascertain that hScrib was indeed a similar target in vivo.
To investigate this, we used primary baby rat kidney cells (BRK cells) as these are primary epithelial cells and approximate to the target cells of HPV in vivo. Primary BRK cells were transiently transfected with a plasmid expressing HA-hScrib, either alone or with plasmids expressing HPV-16 or HPV-18 E6. After overnight incubation, the cells were treated for 2 h with the proteasome inhibitor CBZ, or were mock treated with DMSO alone. The proteins were then analysed by Western blot. In Figure 6 it can be clearly seen that hScrib levels are strongly reduced in the presence of HPV-16 E6 and somewhat less strongly reduced in the (a) A GST pulldown assay was performed using the four PDZ domains of hScrib separately fused to GST. These were incubated with in vitro translated HPV-16 and HPV-18 wild-type E6 and the endswap mutants. After extensive washing the remaining protein was analysed by SDS-PAGE and autoradiography. (b) A GST pulldown assay was performed using GST alone or GST-16E6 together with the following in vitro translated hScrib constructs. Full-length (FL), the four PDZ domains (amino acids 616-1490; 4P), 4PDZ with mutations in each of the PDZ binding loops (M1, M2, M3 and M4). After extensive washing the remaining protein was analysed by SDS-PAGE and autoradiography. The lower panels show the Coomassie-stained gels presence of HPV-18 E6, in agreement with the data obtained in vitro. It can also be seen that the hScrib levels are restored upon proteasome inhibition, indicating that the presence of high-risk HPV E6 proteins induces the proteasome-mediated degradation of hScrib in primary epithelial cells.
Discussion
In this study, we have examined the interactions of HPV-16 and HPV-18 E6 with a known PDZ domaincontaining target protein, hScrib, and have shown that there are significant differences between them. Moreover, we also show that hScrib differs from most other PDZ domain-containing targets of E6 by being more susceptible to HPV-16 E6, rather than HPV-18 E6. We have demonstrated that hScrib has tumour suppressor activity in a classic cell transformation system, and that the respective abilities of the E6 proteins to inhibit this reflect the specificity of their interactions with hScrib.
The Scribble and Dlg proteins have a number of functions, amongst which is participation in a complex that regulates epithelial cell polarity (Woods et al., 1997; Bilder et al., 2003; Tanentzapf and Tepass, 2003; reviewed in Humbert et al., 2003) . The correct functioning of the complex absolutely requires both Dlg and Scribble and thus the fact that both are targeted by highrisk HPV E6 proteins (Gardiol et al., 1999; Nakagawa and Huibregtse, 2000) was interesting as it appeared to be redundant. Previous studies had shown that hScrib could be ubiquitinated in vitro in the presence of HPV-16 E6 and of the uncommon HPV-39 E6. However, no direct comparisons had been made of the relative efficiency with which different HPV E6 proteins could target Scribble, and information on the precise basis of the interaction between E6 and Scribble was scant. Using wild-type hScrib plus a mutant whose PDZ domains were deleted (hScribDPDZ), we have shown that wild-type hScrib is susceptible to degradation in the presence of HPV-16 or HPV-18 E6, whereas the hScribDPDZ is unaffected, thus confirming the PDZdependence of the degradation. Perhaps more interestingly, although HPV-18 E6 could induce the degradation of hScrib, it appeared to be less efficient in doing so than HPV-16 E6.
This was confirmed by a direct comparison with Dlg degradation, which has previously been shown to be more efficiently directed by HPV-18 E6 (Gardiol et al., 1999; Pim et al., 2000 Pim et al., , 2002 . Indeed other PDZ domaincontaining targets, including MUPP1 and MAGI-1, -2 and -3 (Glaunsinger et al., 2000; Thomas et al., 2001 Thomas et al., , 2002 Thomas, unpublished observations) have also been shown to be more efficiently targeted by the HPV-18 E6. This has been shown to be related to the exact sequence of the PDZ-binding motif: ETQV in HPV-18 E6 and ETQL in HPV-16 E6 (Thomas et al., 2001) : the motif found in HPV-18 E6 is the exact consensus, while HPV-16 has been thought to have a suboptimal motif.
We used previously described HPV-16 and HPV-18 proteins, mutated in the PDZ-binding motif (Thomas et al., 2001) , to analyse the effect of the sequence upon E6's activity in targeting hScrib for degradation. Not surprisingly, the mutants in which the binding motif is disrupted had no effect on the stability of the wt hScrib (data not shown), and no E6 protein has any effect upon the stability of the hScribDPDZ mutant, confirming that the interaction occurs via the PDZ domains of hScrib. The endswap mutants, in which the last amino acid is changed, show a completely reversed affinity for hScrib, with 16E6 L151V having almost no activity in inducing degradation while the 18E6 V158L induces complete degradation of the hScrib, confirming the importance of the precise sequence of the PDZ binding motif. This defines a new type of PDZ-containing target for E6-induced degradation: one that has a higher specificity for the HPV-16 ETQL motif. The differences between the virus types in their interactions with these crucial polarity control proteins might suggest that their target cells are not precisely similar.
Our previous work had shown that the interaction of E6 with its PDZ-containing targets occurs through just one of the PDZ domains (Glaunsinger et al., 2000; Gardiol et al., 2002; Thomas et al., 2002) . However, another study appeared to suggest that HPV-16 E6 was able to bind indiscriminately to any or all of the PDZ domains of hScrib (Nakagawa and Huibregtse, 2000) . Using several different constructs of hScrib PDZ domains, expressed either as GST fusion proteins or as truncation mutants expressed in vitro, we have shown that the hScrib PDZ domain 3 is probably the target of choice for the HPV E6 proteins. This difference from the previously published study indicates that nonspecific PDZ binding can occur under insufficiently rigorous conditions and that care is needed to adequately control the assay conditions. Interestingly, the binding assays shown here also demonstrate that HPV-16 E6 binds much more strongly than HPV-18 E6 and that these affinities are considerably altered in the endswap mutants, again pointing to potential differences in the interactions between the viruses and their target cells. It is also interesting that PDZ3 is the reported binding site of LPP (Lipoma Preferred Protein), a protein that shuttles between sites of cell adhesion and the nucleus (Petit et al., 2005) . In view of the finding that it is the nuclear, signalling, pool of Dlg that is targeted by HPV E6s (Massimi et al., 2004) , this may suggest that hScrib with a PDZ3 available for binding is involved in certain signalling roles detrimental to the viral life cycle.
After showing that the HPV-16 and HPV-18 E6 proteins target the hScrib with differing affinities in vitro, it was obvious to check whether these reactions could also occur in an in vivo system and whether they would show the same differences between virus types. A transient transfection in primary epithelial cells (BRK) showed that HPV-16 was again more effective than HPV-18 E6 in inducing the degradation of hScrib, thus confirming the in vitro data. In addition, the presence of proteasome inhibitors rescues the hScrib proteins, showing clearly that the HPV E6 proteins induce the degradation of hScrib via the proteasome. It may also be noted that the hScrib species rescued is predominantly a higher molecular weight form, suggesting that this is the form preferentially targeted by HPV E6 proteins.
Finally, since hScrib had been described as a potential tumour suppressor, it was obviously of interest to determine whether HPV E6 proteins might have any effect upon this potential activity. We have shown here, in a standard oncogene cooperation assay, that hScrib acts a potent inhibitor of primary rodent cell transformation, providing further evidence for its definition as a tumour suppressor. In addition, the presence of HPV-16 E6 abrogates that activity to a large extent, while HPV-18 E6 has only minimal effects, mirroring the in vitro affinities of the viral proteins for hScrib. It should be borne in mind that the levels of E6 and hScrib proteins expressed in these assays are probably supraphysiological and this may result in stronger and more rapid effects than would be seen in a natural infection and/or tumorigenesis. However, this is the first demonstration of hScrib's tumour suppressive activities in a classic mammalian cell transformation system. Long-term studies using transgenic mice will probably clarify the exact relevance of the differences between HPV-16 and HPV-18 in respect of their PDZ domain containing targets.
A number of studies have shown that Dlg and Scribble activities are to a large extent complementary, and the fact that HPV E6 proteins target both of them underlines their importance. However, the fact that HPV-16 and HPV-18 target these proteins differently is also intriguing and suggests that the two viruses might interact differently with this complex in their host cells. In developing Drosophila epithelium, Dlg and hScrib form part of an apico-basal control complex (reviewed in Humbert et al., 2003) , localized on the baso-lateral membrane, just basal to the Zonula Adherens. At the neuromuscular junction, GUK-holder (Mathew et al., 2002) , a protein bearing a PDZ-binding motif, binds to the Scrib PDZ2 domain while its adjacent GUK-holder domain binds to the carboxy terminal GUK homology domain of Dlg. Interestingly, it has been shown that, although both Dlg and Scrib are required for the complete functioning of this complex, Dlg colocalises correctly with GUKh in the absence of Scrib (Mathew et al., 2002) , and thus presumably can act as a scaffolding molecule for at least part of the complex. However, both Dlg and GUKh are required for the recruitment of Scrib to the complex; thus, in the absence of Dlg not even an incomplete complex can form. In mammals, no clear evidence of an interaction between hScrib and Dlg has yet been shown. If such a complex exists, our data suggest that HPV-16 E6 targets the complex through hScrib, disabling part of it, whereas HPV-18 E6 targets the complex through Dlg, preventing its formation. Given that Dlg is epistatic to hScrib in Drosophila in the formation of this complex, the findings described in this paper might partially explain the more aggressive phenotype of HPV-18-containing tumours.
Materials and methods
Plasmids
The following plasmids have been described previously for in vitro expression: pSP64:HPV-16 and pSP64:HPV-18 wild-type E6 (Pim et al., 1994) , the pSP64:HPV-16 L151V and the pSP64:HPV-18 V158L mutant E6s (Thomas et al., 2001) .
For both in vitro and in vivo expression pCDNA:Dlg has been described previously (Gardiol et al., 1999) .
pCDNA:HA-hScrib, pCDNA:HA-hScribDPDZ (deleted from aa724 to aa1224) and pCDNA-HA:hScribPL (Proline 305 to Leucine) were constructed using the Gateway recombination system, and were used for both in vitro and in vivo expression.
pCDNA-hScrib4PDZ, encompassing all four wild-type hScrib PDZ domains (aa 616-1490), and its mutants in the carboxylate binding loop of each PDZ domain, pCDNAhScrib4PDZM1, M2, M3 and M4, have been described previously (Petit et al., 2005) and were the kind gift of M Petit.
For in vivo expression pCDNA:11E6, pCDNA:16E6 and pCDNA:18E6 have been described previously (Pim et al., 1994) .
For GST fusion protein expression pGEX2T:16E6 and pGEX2T:18E6 have been described previously (Pim et al., 2000) . The pGEX2T:18E6V158L was constructed from the pGEX2T:18E6 using the GeneTailor kit (Invitrogen). The pGEX:PDZ1 (aa735-815), pGEX:PDZ2 (aa869-950), pGEX:PDZ3 (aa1011-1092) and pGEX:PDZ4 (aa1108-1192) were constructed using the Gateway recombination system.
In vitro degradation assays
Proteins were transcribed and translated in vitro in rabbit reticulocyte lysate using the Promega TNT system according to the manufacturer's instructions. The HPV E6 proteins and hScrib proteins were radiolabelled with [35S]-cysteine while the Dlg was radiolabelled with [35S]-methionine. Degradation assays were performed as previously described (Thomas et al., 2001) . Briefly, calculated amounts of the radiolabelled proteins were mixed and incubated for the indicated times at 301C. Volumes were adjusted using water-primed lysate. The remaining Dlg or hScrib proteins were immunoprecipitated with anti-Dlg polyclonal rabbit serum (Gardiol et al., 1999) or anti-HA mouse monoclonal antibody (Roche), respectively, and analysed by SDS-PAGE and autoradiography.
GST pulldown assays
GST fusion proteins were expressed in E. coli. as described previously (Pim et al., 2000) . Briefly, overnight cultures were inoculated into fresh medium and incubated for 1 h, after which GST fusion protein expression was induced by the addition of 1mM IPTG (Sigma) for 3 h. The bacteria were harvested, resuspended in PBS/1% Triton X-100 plus protease inhibitors and sonicated. The supernatant was incubated with Glutathione agarose (Sigma) for 1 h at 41C on a rotating wheel. After extensive washing, the immobilized fusion proteins were incubated with calculated amounts of in vitro translated radiolabelled protein at 41C for 1 h before being extensively washed with PBS/1% Nonidet-P40 plus protease inhibitors. In each assay the GST fusion proteins were present in gross excess to obviate any potential limiting concentration and the levels of input in vitro translated proteins were balanced. The retained protein was analysed by SDS-PAGE and autoradiography plus phosphorimager analysis to obtain the percentage of load retained. The gels were rehydrated and stained with Coomassie Brilliant Blue to control for GST fusion protein loading. The binding assays using the 4PDZ mutants of hScrib, described in Figure 4b , were performed under more stringent conditions, with the binding and washing steps being performed in PBS/ 2% Triton X-100, 0.5% Nonidet-P40 plus protease inhibitors.
Cell culture
MDCKII cells were grown in DMEM containing 10% FCS, 100 units/ml penicillin and, 100 mg ml streptomycin sulphate. Transfections were performed on MDCKII cells using the polyFECT reagent (Qiagen), according to the manufacturer's instructions. MDCKII cells stably expressing GFP-hScrib fusions were done as described previously (Navarro et al., 2005) .
BRK cells were also grown in DMEM containing 10% FCS, 100 units/ml penicillin and, 100 mg ml streptomycin sulphate.
Immunofluorescence and confocal microscopy MDCKII cells were grown on Transwell filters, washed twice in PBS, 0.1 mM. Ca 2 þ /1 mM Mg 2 þ , and fixed for 20 min in 4% paraformaldehyde at 41C. Cells were permeabilised for 5 min with 0.5% Triton X-100 at room temperature and blocked in 0.25% gelatine for 1 h at room temperature. The anti-b-catenin antibody (BD Bioscience) diluted in the blocking buffer was incubated overnight at 41C. After four washes of 15 min, cells were incubated for 1 h at room temperature with secondary antibodies coupled to fluorescent probes. Cells were washed and filters were mounted in Dako (Jackson laboratories) for Confocal microscopy analysis.
Degradation assays in vivo
BRK cells (see below) were transfected using Lipofectamin (Invitrogen), according to the manufacturer's instructions, with pCDNA-HA-hScrib either alone or with pCDNA-HPV-16 E6 or pCDNA-HPV-18 E6. A plasmid expressing b-galactosidase was included in each transfection and pCDNA was used to equalize the input DNA. After overnight incubation the cells were treated either with 50 mM CBZ (final concentration) in DMSO, or with DMSO alone. After 2 h, protein extracts were analysed by SDS-PAGE and Western blotting, as described previously (Massimi et al., 2004) . The blots were probed with anti-HA monoclonal antibody (Roche) and visualized using the ECL system (Amersham), according to the manufacturer's instructions. Blots were reprobed for b-galactosidase to control for transfection efficiency.
BRK transformation assays
Primary epithelial cells were obtained from the kidneys of 9-day-old Wistar rats as described previously (Thomas et al., 1999) . After 24 h, the cells were transfected by calcium phosphate precipitation (Wigler et al., 1979) with plasmids expressing EJ-ras plus HPV-16 E7, together with the relevant plasmids expressing hScrib or HPV E6 proteins, as indicated. The cells were maintained under G418 selection for 2 weeks and then fixed, stained with Giemsa, and the colonies counted.
